Translational Psychiatry

Our research focuses on the pathophysiology of mental disorders, their early detection, and their prevention and treatment.

News

Awards
Open Science Award 2024 for Dr. Léon Franzen
Talks
Dyslexia can make you richer (@Nights of open Knowledge; Nook 2024)
Publications
Individualized pretest risk estimates to guide treatment decisions in patients with clinical high risk for psychotic disorders
Publications
Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine
Talks
Ketamine therapy for severe depression
Events
Reminder BEATS-Symposium 2024
01/03

Mission

We strive to improve the prediction of psychotic disorders in young high-risk patients, and investigate the neurofunctional mechanisms and efficacy of potential innovative treatments such as cannabinoids and psychedelics. We apply a variety of methods in pharmacological and clinical studies.

02/03

About us

We are an interdisciplinary team consisting of scientists and health care personnel from the fields of psychiatry, psychology, physicians/medicine, neurosurgery, neurophysiology, mathematics, and biomedical engineering. We drive innovative, translational science forward by combining our diverse set of expertise.

03/03

Research

Our research combines clinical excellence in early intervention with extensive expertise in conducting interdisciplinary research in several key areas revolving around psychotic disorders. These include their prediction, neurofunctional and cognitive mechanisms, and efficacy of potential innovative treatments. We run a variety of pharmacological, clinical, and intervention studies that will support the development of tools for individualized prediction and treatment.

Scroll to Top